Abstract
Objective: Review the correlation between COVID-19 and myocarditis, taking into account the pathophysiological mechanisms, diagnostic methods and therapeutic approach. Bibliographic review: SARS-CoV-2 can invade the host's organism and develop a condition composed of three phases: the initial phase of infection, pulmonary and super inflammation. It is in the latter that damage to the cardiovascular system usually occurs, in which the virus proliferates in the immune system and invades the cardiomyocytes, leading to a myocardial inflammation and cardiac reshuffle and consequently myocarditis. Complementary exams like transthoracic echocardiography, electrocardiogram, ultrasensitive T Troponin and cardiological magnetic resonance are important in the diagnostic investigation of myocarditis. As to the treatment, the clinical situation should be considered and involves support therapies with relief symptoms as a goal. Final considerations: Myocarditis is an increasingly reported cardiology complication of SARS-CoV-2 infection, and it is essential that healthcare professionals have knowledge of the pathophysiology and clinical features of the disease, as well as the related risk factors, for early diagnosis and interventions.